⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

Epitalon

Also known as: Epithalon, Epithalone, Ala-Glu-Asp-Gly, AEDG

Epitalon (AEDG) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is the most studied of the Khavinson bioregulators, researched primarily for telomerase activation, pineal gland regulation, and anti-aging effects.

Last updated: February 1, 2025Reviewed by: PeptideHub Research Team

Epitalon is a 390.35 Da research peptide. Epitalon (AEDG) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is the most studied of the Khavinson bioregulators, researched primarily for telomerase activation, pineal gland regulation, and anti-aging effects.

Also called: Epithalon, Epithalone, Ala-Glu-Asp-Gly

390.35

Molecular Weight

Daltons

0

Strong Evidence

benefits

5

Studies Cited

peer-reviewed

5000-10000

Typical Dose

mcg

Overview

Epitalon is a synthetic tetrapeptide consisting of four amino acids; Alanine-Glutamic acid-Aspartic acid-Glycine (AEDG). It was developed as a synthetic analog of Epithalamin, a polypeptide extract from the pineal gland, by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. Khavinson's research program, spanning over 40 years, is based on the concept that short peptides can regulate gene expression in specific tissues, restoring function that declines with aging. Epitalon is the most extensively studied of these bioregulatory peptides. The primary research claims center on telomerase activation, Epitalon has been shown in cell culture and animal studies to activate the enzyme telomerase, which lengthens telomeres (the protective caps on chromosomes that shorten with each cell division and are associated with cellular aging). Additional research suggests Epitalon regulates melatonin synthesis in the pineal gland, modulates circadian rhythms, has antioxidant properties, and may influence the neuroendocrine system. Animal studies have reported significant lifespan extension in rodent models. While the Russian research is extensive (over 100 publications), much of it is published in Russian-language journals and has not been extensively replicated by independent Western laboratories, which is an important consideration when evaluating the evidence base.

Key Takeaways: Epitalon

  • Research doses typically range from 5000 to 10000 mcg via subcutaneous injection
  • 0 benefits with strong evidence, 3 moderate, 3 preliminary
  • Half-life: Minutes (very short — typical of small peptides)
  • 5 cited research studies in this guide

Mechanism of Action

Epitalon's proposed primary mechanism is the activation of telomerase, the ribonucleoprotein enzyme that adds TTAGGG telomeric repeats to chromosome ends. In cell culture studies, Epitalon increased the expression of the human telomerase reverse transcriptase (hTERT) gene, the catalytic subunit of telomerase, in human somatic cells that normally have repressed telomerase activity. This telomere elongation is proposed to extend the replicative lifespan of cells, counteracting the Hayflick limit. In the pineal gland, Epitalon is reported to stimulate melatonin synthesis by upregulating the enzymes involved in melatonin production (serotonin N-acetyltransferase and hydroxyindole-O-methyltransferase), potentially restoring the age-related decline in melatonin secretion. Khavinson's bioregulation theory proposes that short peptides interact with specific DNA sequences, modulating gene expression at the chromatin level without requiring traditional receptor-mediated signaling. Research suggests Epitalon may interact with histone proteins and influence chromatin condensation/decondensation, thereby regulating the accessibility of specific genes. Additional proposed mechanisms include antioxidant effects (increased superoxide dismutase and glutathione peroxidase activity), normalization of circadian cortisol rhythms, and regulation of the hypothalamic-pituitary axis. While the mechanistic data is intriguing, the bioregulation theory of direct peptide-DNA interaction remains outside mainstream molecular biology consensus.

Research Benefits

Epitalon at a Glance

Primary mechanism:

Epitalon's proposed primary mechanism is the activation of telomerase, the ribonucleoprotein enzyme that adds TTAGGG telomeric repeats to chromosome ends.

Top researched benefits:
Telomerase ActivationMelatonin Production RestorationLifespan Extension (Animal Models)Antioxidant EnhancementNeuroendocrine RegulationRetinal Protection

Telomerase Activation

Moderate Evidence

Cell culture studies show Epitalon activates telomerase (hTERT expression) in human somatic cells, elongating telomeres and extending cellular replicative lifespan beyond the Hayflick limit.

Melatonin Production Restoration

Moderate Evidence

Animal studies demonstrate Epitalon restores age-related decline in pineal melatonin synthesis, normalizing circadian melatonin rhythms in aged organisms.

Lifespan Extension (Animal Models)

Moderate Evidence

Multiple rodent studies report significant lifespan extension (10-25%) with Epitalon treatment, with reduced spontaneous tumor incidence in aging animals.

Antioxidant Enhancement

Preliminary

Research shows increased activity of endogenous antioxidant enzymes (SOD, glutathione peroxidase) and reduced lipid peroxidation markers in Epitalon-treated animals.

Neuroendocrine Regulation

Preliminary

Proposed restoration of age-related hypothalamic-pituitary axis dysfunction, with normalization of cortisol rhythms and improved circadian regulation.

Retinal Protection

Preliminary

Studies in retinal pigment epithelium cells show Epitalon preserves retinal structure and function, with potential applications for age-related retinal degeneration.

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
Standard anti-aging research protocol500010000 mcgSubcutaneous injection
Khavinson clinical protocol1000010000 mcgIntramuscular injection, 10-day courses
Maintenance / lower dose protocol10005000 mcgSubcutaneous injection

Frequency

Once daily during treatment courses

Timing

Evening administration preferred (aligns with pineal/melatonin mechanism)

Cycle Length

10-20 day courses, repeated 2-3 times per year (Khavinson protocol)

Research Notes

  • 1The Khavinson protocol uses 10-day intensive courses repeated every 4-6 months.
  • 2Subcutaneous injection is the most common route outside Russian clinical settings.
  • 3Intranasal and sublingual administration have been explored but with less data.
  • 4Evening dosing may align with the pineal/melatonin mechanism.
  • 5Most research is from Russian institutions; independent Western replication is limited.
  • 6No serious adverse effects reported in published Russian clinical studies.

Reconstitution Guide

Standard Reconstitution

Vial Size

10 mg

Bacteriostatic Water

2 mL

Concentration

50 mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

Epitalon vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 2 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at Refrigerated (2-8°C / 36-46°F) after reconstitution. Up to 30 days refrigerated after reconstitution.

Storage Temperature

Refrigerated (2-8°C / 36-46°F) after reconstitution

Shelf Life

Up to 30 days refrigerated after reconstitution

Important Notes

  • Reconstitute with bacteriostatic water.
  • Epitalon is a small, stable tetrapeptide — relatively strong compared to larger peptides.
  • Swirl gently; do not shake.
  • Store lyophilized powder at room temperature or refrigerated.
  • Clear, colorless solution after reconstitution.

Safety & Side Effects

Reported Side Effects

  • !Injection site reactions (mild, transient)
  • !No significant adverse effects reported in published clinical studies
  • !Headache (rare, reported anecdotally)
  • !Mild drowsiness (may be related to melatonin effects, especially with evening dosing)
  • !Extremely well tolerated in published research; Khavinson reports no serious adverse events across decades of clinical use
  • !Long-term safety data limited to Russian institutional studies

Potential Interactions

  • May potentiate melatonin supplements or medications affecting melatonin (additive circadian effects).
  • Theoretical interaction with telomerase-modulating cancer therapies.
  • No significant adverse interactions reported in published literature.
  • May complement other Khavinson bioregulators (frequently used in combination protocols).
  • Caution in active cancer, telomerase activation is a feature of many cancers (theoretical concern).

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Peptide promotes telomere elongation in human somatic cells

Khavinson VKh, et al.2003Bulletin of Experimental Biology and Medicine
PMID: 14714063

Demonstrated Epitalon (AEDG) activates telomerase and elongates telomeres in human fetal lung fibroblast cultures, extending replicative lifespan beyond the Hayflick limit by 10 additional population doublings.

Epitalon increases lifespan and reduces tumor incidence in rodents

Anisimov VN, et al.2003Experimental Gerontology
PMID: 12954341

Showed chronic Epitalon treatment increased mean lifespan by 13.3% in female CBA mice, with significant reduction in spontaneous tumor development in aging animals.

Epitalon restores melatonin production in aging monkeys

Khavinson VKh, et al.2001Neuroendocrinology Letters
PMID: 11524638

Demonstrated Epitalon restored age-related decline in nocturnal melatonin secretion in aging Macaca mulatta monkeys, normalizing circadian melatonin patterns toward youthful levels.

Short peptides regulate gene expression: bioregulation theory

Khavinson VKh.2009Bulletin of Experimental Biology and Medicine

thorough overview of Khavinson's bioregulation theory, proposing that short peptides (2-4 amino acids) regulate gene expression by interacting with specific DNA sequences and modulating chromatin structure.

Epitalon protects retinal pigment epithelium from age-related degeneration

Khavinson VKh, et al.2014Advances in Gerontology

Showed Epitalon preserves retinal pigment epithelium cell structure and function in cell culture and animal models, with potential therapeutic implications for age-related macular degeneration.

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Epitalon (AEDG) is a synthetic tetrapeptide developed by Professor Khavinson in Russia. It is researched for anti-aging effects, primarily through telomerase activation (elongating telomeres) and restoring pineal melatonin production. It is the most studied of the Khavinson bioregulatory peptides.

Cell culture studies show Epitalon increases hTERT (telomerase catalytic subunit) expression and extends cellular replicative lifespan. However, most of this research comes from Russian institutions and has not been extensively replicated by independent Western laboratories.

This is an important concern. Telomerase activation is a hallmark of many cancers. Published animal studies actually show reduced tumor incidence with Epitalon, suggesting the telomerase activation may be regulated rather than constitutive. However, caution is warranted in individuals with active cancer or cancer history.

Epithalamin is a polypeptide extract from the pineal gland containing multiple peptides. Epitalon (AEDG) is a synthetic tetrapeptide designed as the active component responsible for Epithalamin's primary biological effects. Epitalon is defined, reproducible, and easier to manufacture.

The evidence base includes over 100 publications, primarily from Russian institutions led by Professor Khavinson. While the research is extensive and includes animal and some human studies, independent Western replication is limited. The bioregulation theory is not widely accepted in mainstream molecular biology.

In the Khavinson protocol, Epitalon is frequently combined with tissue-specific bioregulators (Pinealon, Cortagen, etc.) in sequential or overlapping courses. No adverse interactions between Khavinson bioregulators have been reported.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.